Applications of 5A-Androstanedione in Industrial Manufacturing

As a specialized manufacturer of 5A-Androstanedione, we supply this intermediate to established industries that require precision and traceability in sourcing, formulation, and process integration. The following sections detail how downstream clients apply this raw material in distinct industrial domains, meeting regulated standards and specific technical requirements.

1. Pharmaceutical Steroid API Synthesis

Steroid pharmaceutical companies incorporate 5A-Androstanedione for the synthesis of key active pharmaceutical ingredients, leveraging its role as a core intermediate in the transformation to androgens and related hormones. The material enters multi-stage synthesis lines, frequently enzymatic or chemical, requiring precise molar ratios to ensure conversion and product consistency. Companies must adhere to strict pharmacopeial criteria throughout production and QC, as the resulting APIs act as the base substances for regulated hormone formulations.

Industry compliance standards

• Current Good Manufacturing Practices (cGMP), ICH Q7
• United States Pharmacopeia (USP), European Pharmacopoeia (Ph. Eur.), Chinese Pharmacopoeia (ChP)
• FDA and EMA API manufacturing guidelines
• Regulations on Precursors and Essential Chemicals (where applicable)

Typical usage ratio

• Used at 1.0–2.8 mol equiv in steroid synthesis batches, depending on target hormone and process yield optimization; ratio adjusted for purity of input and target conversion efficiency

Downstream process integration

• Introduced at the initial or intermediate stage of chemical synthesis lines, often after multi-step purification and analysis; may involve biotransformation using specific microbial strains or catalytic hydrogenation for further modification

Final product types

• Testosterone derivatives (e.g., Dihydrotestosterone, Mestanolone API)
• Finasteride and related 5α-reductase inhibitors
• Anabolic steroid APIs for medicinal use
• Intermediates for veterinary pharmaceuticals

2. Production of Androgen Receptor Modulators

Research-based contract manufacturing organizations (CMOs) and specialty pharma producers utilize 5A-Androstanedione to synthesize investigational androgen receptor modulators. This application demands integration within peptide or heterocyclic compound assembly, with stringent controls over both trace contaminants and molecular pathway selectivity. Regulatory adherence applies both to bulk process environments and to the novel compound registration at the research and clinical trial stage.

Industry compliance standards

• GLP (Good Laboratory Practice) for R&D syntheses
• cGMP (21 CFR Parts 210–211) for pilot and clinical-grade batch production
• EMA and FDA investigational drug regulations
• Material Transfer Agreement recordkeeping

Typical usage ratio

• Generally 1.5–3.0% mol concentration in synthetic multi-component reactions; precise proportion determined by target molecule, route of synthesis, and scale-up parameters

Downstream process integration

• Added as a substrate in stepwise or one-pot synthesis of SARMs, with in-process control assays at each transformation; further processed to API format post-purification

Final product types

• Selective Androgen Receptor Modulator (SARM) drug leads
• Early-phase clinical trial compounds (Phase I / II)
• Reference standards for bioanalytical laboratories

3. Veterinary Hormone and Growth Promoter Synthesis

Manufacturers serving the animal health sector employ 5A-Androstanedione to generate key intermediates for controlled veterinary hormone preparations and approved growth promoters in livestock. Production lines deploy specific conversions optimized for cost and performance, reflecting regulatory limitations on residue levels and mandatory batch record traceability.

Industry compliance standards

• Veterinary Drug GMP (China, EU, US)
• VICH GL24 (Validation of Analytical Methods)
• Relevant local food safety and residue limits (e.g., EU Council Regulation 2377/90, FDA CVM Guidance)
• Active Substance Master File (ASMF) requirements for veterinary use

Typical usage ratio

• Utilized at 1.0–2.5% by weight within synthesis workflows of hormone intermediates; exact percentage controlled by conversion pathway, desired yield, and compliance with end-use content thresholds

Downstream process integration

• Fed into staged synthesis reactors as a precursor to veterinary-grade anabolic/androgenic hormones; processed using both isolation and recrystallization steps to reach required purity

Final product types

• Bovine and porcine growth promoter premixes (where regulations allow)
• Veterinary steroid hormone APIs
• Hormone implant formulations

4. Endocrine Research Reagent Manufacturing

Suppliers to academic, clinical, and biotechnology research markets use 5A-Androstanedione in the formulation of assay kits, reference standards, and internal laboratory controls for endocrine pathway analysis. Material traceability and batch-to-batch consistency are essential to ensure reproducibility of research outcomes and to meet supplier accreditation requirements.

Industry compliance standards

• ISO 13485 for medical laboratory reagent manufacturing
• ISO 17034/ISO Guide 34 for certified reference material production
• OECD Guidelines for the Testing of Chemicals
• Quality Management Systems for Research Use Only (RUO) materials

Typical usage ratio

• Formulated at 0.01–0.1% in biochemical assay kits and at 95–99.5% purity for reference standards; adjusted based on sensitivity requirements and assay calibration

Downstream process integration

• Applied during microplate coating, enzyme-linked immunoassay kit assembly, or as a purified solid standard; may undergo additional analytical verification prior to packaging

Final product types

• ELISA kits and biochemical assay reagents for androgen quantification
• Certified reference standards for analytical laboratories
• Internal standards for mass spectrometry or LC-MS validation in research settings